Topic
40 recent stories.
Policy / European Union
The European Medicines Agency's PRIME initiative aims to expedite the development and assessment of innovative treatments, focusing on medications addressing high unmet medical needs.
08 May 2026
Policy / European Union
The European Medicines Agency has issued a positive opinion on the Dengue Tetravalent Vaccine (Live, Attenuated) created by Takeda for use outside the EU, highlighting its effectiveness in preventing severe dengue disease in children and adolescents.
08 May 2026
Policy / European Union
The European Medicines Agency has initiated a safety review of certain combination pain relief medications, including those containing buclizine and codeine. The decision reflects ongoing efforts to ensure the safety of pharmaceutical products in the EU.
08 May 2026
Policy / European Union
The European Medicines Agency has authorized Tenofovir Disoproxil Viatris, a generic drug to treat HIV and Hepatitis B, underlining its safety and effectiveness compared to its reference medicine, Viread.
08 May 2026
Policy / European Union
The European Parliament's Transport Committee has proposed a new draft opinion creating a fund aimed at enhancing economic, social, and territorial cohesion across the EU for the 2028-2034 period.
08 May 2026
Policy / European Union
Strimvelis, an innovative gene therapy for treating severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), has been approved for use in the EU, offering hope to patients without suitable bone marrow donors.
08 May 2026
Policy / European Union
Talmanco, a new generic medicine for pulmonary arterial hypertension (PAH), has been granted marketing authorization by the European Commission, providing an alternative treatment option for patients.
08 May 2026
Policy / European Union
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency reviewed crucial safety policies during its May meeting, highlighting no new safety referrals or urgent actions.
08 May 2026
Culture / European Union
On May 9, 2026, Europe celebrates Europe Day, marking the 76th anniversary of the Schuman Declaration and 40 years of membership for Spain and Portugal in the EU. A series of celebratory events will take place across Member States, emphasizing unity and democracy.
08 May 2026
Policy / European Union
Pregabalin Viatris, a generic form of the widely used medication Lyrica, has been formally recognised by the European Medicines Agency for its efficacy in treating neuropathic pain and anxiety disorders in adults.
08 May 2026
Policy / European Union
The European Parliament's Environment Committee has put forward a series of amendments aimed at updating regulations concerning crops produced through new genomic techniques.
08 May 2026
Policy / Europe
French prosecutors have escalated their investigation into Elon Musk's social platform X, now formally including criminal charges regarding child sexual abuse images, deepfakes, and allegations of complicity in systemic disinformation.
08 May 2026
Policy / European Union
Dupixent (dupilumab) has been officially recognized for its efficacy in treating various chronic inflammatory diseases, marking a significant advance in therapeutic options since its authorization in 2017.
08 May 2026
Policy / European Union
Christine Lagarde, President of the European Central Bank, emphasized the importance of understanding stablecoins' separate functions in a speech at the Banco de España LatAm Economic Forum. With their rapid rise, she urged Europe to consider its own euro-denominated stablecoins to avoid digital dollarisation.
08 May 2026
Policy / European Union
In a recent speech, Isabel Schnabel emphasized the rising pressures facing central banks, undermining their independence and ability to ensure economic stability. With concerns over government debt and financial deregulation, the future of monetary policy could be at risk.
07 May 2026
Policy / European Union
Mysildecard, a generic form of sildenafil, has received EU approval for treating pulmonary arterial hypertension in both adults and children. The treatment aims to improve exercise capacity by dilating blood vessels in the lungs.
07 May 2026
Policy / European Union
The Environment Committee of the European Parliament held discussions aimed at enhancing public health and food safety, marking significant progress in EU environmental legislation.
07 May 2026
Policy / European Union
The European Parliament's Transport Committee has proposed amendments to existing directives regarding CO2 emissions for heavy-duty vehicles. The aim is to enhance sustainability in road transport by clarifying emission classifications.
07 May 2026
Policy / European Union
The European Medicines Agency has authorized Darunavir Viatris, a generic antiviral medication for treating HIV-1 infection, emphasizing its bioequivalence to the reference drug Prezista.
07 May 2026
Policy / European Union
The European Banking Authority emphasizes its commitment to safeguarding the EU banking sector and enhancing financial stability during its latest update.
07 May 2026
Policy / European Union
Loqtorzi, a monoclonal antibody for cancer treatment, receives EU marketing authorization due to its promising efficacy in extending survival for patients with advanced nasopharyngeal and esophageal cancers, despite known side effects.
07 May 2026
Policy / European Union
The European Banking Authority (EBA) focuses on enhancing the stability and effectiveness of the EU financial system through regulatory harmonisation and risk analysis.
07 May 2026
Policy / European Union
The Environment Committee of the European Parliament convened on February 9, 2026, addressing crucial legislative measures aimed at enhancing public health and environmental safety across the EU.
07 May 2026
Policy / European Union
The European Parliament's Security and Defence Committee held a significant meeting to address pressing security concerns faced by EU member states.
07 May 2026
Policy / European Union
A recent joint committee meeting in the European Parliament focused on the intersection of energy policy and security concerns, as Europe grapples with energy dependencies.
07 May 2026
Policy / European Union
The European Parliament's Industry, Research and Energy Committee has endorsed a comprehensive draft decision regarding the Research Programme of the Research Fund for Coal and Steel, setting out new technical and financial guidelines.
07 May 2026
Policy / European Union
The European Parliament's Transport Committee convened to discuss strategies aligning transport policies with environmental goals on March 17, 2026. Several critical topics were reviewed, showcasing the EU’s commitment to sustainable transport solutions.
07 May 2026
Policy / Europe
European Union states and the Parliament have provisionally agreed to a streamlined approach to AI legislation, aiming to reduce legal complexities for businesses while maintaining safety standards.
07 May 2026
Policy / European Union
The European Medicines Agency (EMA) has reaffirmed the approval of CellCept, a vital immunosuppressant used to prevent organ rejection in transplant patients, seen as more effective than alternatives.
07 May 2026
Policy / European Union
The European Union Aviation Safety Agency introduces Revision 24 of the Easy Access Rules, featuring a new online format for enhanced accessibility and continuous updates.
07 May 2026
Policy / European Union
The European Union Aviation Safety Agency (EASA) and the International Air Transport Association (IATA) have signed a Memorandum of Understanding aimed at enhancing clarity in air travel emissions data. This collaboration seeks to streamline processes related to the European Union Flight Emissions Label.
07 May 2026
Policy / European Union
Uplizna (inebilizumab), effective for reducing NMOSD and IgG4-related disease symptoms, has gained conditional approval in the EU. Key usage protocols and safety guidelines are outlined for healthcare providers.
07 May 2026
Policy / European Union
African and European parliamentarians will convene in Eswatini from May 12-14 to address key issues such as security, youth policy, and strategic resource management.
07 May 2026
Policy / European Union
The European Parliament's Industry, Research and Energy Committee has released a mission report detailing findings from a recent trip to key energy sites in France, aimed at enhancing EU energy policy.
07 May 2026
Policy / European Union
The European Parliament's Environment Committee has proposed the establishment of the European Competitiveness Fund, aiming to enhance support for defence research and innovation.
07 May 2026
Policy / European Union
An eight-member delegation from the European Parliament's ITRE Committee embarked on a mission to France, focusing on key industrial sectors and the energy transition, showcasing the country's commitments to aerospace and clean technologies.
07 May 2026
Policy / European Union
The European Medicines Agency has authorized Kerendia (finerenone), a new treatment for adults with chronic kidney disease linked to type 2 diabetes, citing its benefits in slowing kidney function decline and reducing cardiovascular risks.
07 May 2026
Policy / European Union
The European Parliament's Industry, Research and Energy Committee has released amendments to the draft report on the Connecting Europe Facility, setting the stage for transformative infrastructure investments across the EU for the next funding period.
07 May 2026
Policy / European Union
The European Parliament's Transport Committee has advanced amendments for the Connecting Europe Facility, shaping the future of transportation infrastructure and compliance.
07 May 2026
Policy / European Union
Dovprela, an antibiotic for multidrug-resistant tuberculosis, has received standard authorisation from the European Medicines Agency, moving beyond its initial conditional approval.
07 May 2026